T: 416-862-4836 email JulieView full profile.
T: 613-761-2424 email CharlesView full profile.
T: 416-862-4837 email RichardView full profile.
T: 613-217-8521 email John View full profile.
T: 416-862-4825 email MatthewView full profile.
T: 416-862-4826 email JohnView full profile.
T: 416-862-4820 email MarcView full profile.
T: 416-862-4831 email CarlView full profile.
T: 416-642-4874 email AlessiaView full profile.
T: 416-642-4877 email KipView full profile.
T: 416-642-4876 email SydneyView full profile.
T: 416-862-4823 email AmandaView full profile.
T: 416-862-4829 email AnandView full profile.
T: 416-862-4828 email JacquelynView full profile.
T: 416-862-4835 email JenniferView full profile.
T: 416-862-4830 email JoannaView full profile.
T: 416-642-4873 email LaurenView full profile.
Environment • Aboriginal • Energy
The federal Pest Management Regulatory Agency (PMRA) will reevaluate 23 active ingredients currently found in some 360 pest control products registered for use in Canada. PMRA announced the review of the ingredients on December 30, 2013 following an Application for Judicial Review filed in the Federal Court last August by Ecojustice on behalf of Équiterre and the David Suzuki Foundation. Active ingredients under the microscope include weed killers 2,4-D, bromoxynil and atrazine; insecticides carbaryl, dichlorvos and diazinon; and the wood preservative pentachlorophenol. PMRA will notify registrants of the review, and may ask some for information. If information is requested, registrants must demonstrate to PMRA that the health and environmental risks, as well as the value of the pest control product, are acceptable.
PMRA’s proposed approach for the special review is open for comment until February 14, 2014.
Active Ingredients Under Review
2,4-D
Chloropicrin
Diphenylamine
Paraquat
Acephate
Chlorthal-dimethyl
Fluazifop-P-butyl
Pentachlorophenol
Aminopyralid
Diazinon
Fluazinam
Quintozene
Atrazine
Dichlobenil
Hexazinone
Simazine
Bromoxynil
Dichlorvos
Imazapyr
Trifluralin
Carbaryl
Difenoconazole
Linuron
To read the rest of the article, click here.